Therapeutic uses of recombinant complement protein inhibitors

por Kalli, Kimberly R., Hsu, Peihong, Fearon, Douglas T.
Publicado 1994

Toward understanding the genetics of regulatory T cells in ovarian cancer

por DeRycke, Melissa S, Charbonneau, Bridget, Preston, Claudia C, Kalli, Kimberly R, Knutson, Keith L, Rider, David N, Goode, Ellen L
Publicado 2013

Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer

por Chien, Jeremy, Neums, Lisa, Powell, Alexis F. L. A., Torres, Michelle, Kalli, Kimberly R., Multinu, Francesco, Shridhar, Viji, Mariani, Andrea
Publicado 2018

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival

por Jatoi, Aminah, Foster, Nathan R., Kalli, Kimberly R., Vierkant, Robert A., Zhang, Zhiying, Larson, Melissa C., Fridley, Brooke, Goode, Ellen L.
Publicado 2015

The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

por Preston, Claudia C., Maurer, Matthew J., Oberg, Ann L., Visscher, Daniel W., Kalli, Kimberly R., Hartmann, Lynn C., Goode, Ellen L., Knutson, Keith L.
Publicado 2013

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()

por Butler, Kristina A., Hou, Xiaonan, Becker, Marc A., Zanfagnin, Valentina, Enderica-Gonzalez, Sergio, Visscher, Daniel, Kalli, Kimberly R., Tienchaianada, Piyawan, Haluska, Paul, Weroha, S. John
Publicado 2017

Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients

por Basal, Eati, Eghbali-Fatourechi, Guiti Z., Kalli, Kimberly R., Hartmann, Lynn C., Goodman, Karin M., Goode, Ellen L., Kamen, Barton A., Low, Philip S., Knutson, Keith L.
Publicado 2009

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review

por Mehner, Christine, Oberg, Ann L., Goergen, Krista M., Kalli, Kimberly R., Maurer, Matthew J., Nassar, Aziza, Goode, Ellen L., Keeney, Gary L., Jatoi, Aminah, Radisky, Derek C., Radisky, Evette S.
Publicado 2017

Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer

por Koestler, Devin C, Chalise, Prabhakar, Cicek, Mine S, Cunningham, Julie M, Armasu, Sebastian, Larson, Melissa C, Chien, Jeremy, Block, Matthew, Kalli, Kimberly R, Sellers, Thomas A, Fridley, Brooke L, Goode, Ellen L
Publicado 2014

Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers

por Harris, Faye R., Kovtun, Irina V., Smadbeck, James, Multinu, Francesco, Jatoi, Aminah, Kosari, Farhad, Kalli, Kimberly R., Murphy, Stephen J., Halling, Geoffrey C., Johnson, Sarah H., Liu, Minetta C., Mariani, Andrea, Vasmatzis, George
Publicado 2016

Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer

por Natanzon, Yanina, Earp, Madalene, Cunningham, Julie M, Kalli, Kimberly R, Wang, Chen, Armasu, Sebastian M, Larson, Melissa C, Bowtell, David DL, Garsed, Dale W, Fridley, Brooke L, Winham, Stacey J, Goode, Ellen L
Publicado 2018

Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome

por Fridley, Brooke L, Armasu, Sebastian M, Cicek, Mine S, Larson, Melissa C, Wang, Chen, Winham, Stacey J, Kalli, Kimberly R, Koestler, Devin C, Rider, David N, Shridhar, Viji, Olson, Janet E, Cunningham, Julie M, Goode, Ellen L
Publicado 2014

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer

por Wang, Chen, Winterhoff, Boris J, Kalli, Kimberly R, Block, Matthew S, Armasu, Sebastian M, Larson, Melissa C, Chen, Hsiao-Wang, Keeney, Gary L, Hartmann, Lynn C, Shridhar, Viji, Konecny, Gottfried E, Goode, Ellen L, Fridley, Brooke L
Publicado 2016

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic

por Hendrickson, Andrea Wahner, Hawthorne, Kieran M., Goode, Ellen L., Kalli, Kimberly R., Goergen, Krista M., Bakkum-Gamez, Jamie N., Cliby, William A., Keeney, Gary L., Visscher, Dan W., Tarabishy, Yaman, Oberg, Ann L., Hartmann, Lynn C., Maurer, Matthew J.
Publicado 2015

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes

por Earp, Madalene A, Raghavan, Rama, Li, Qian, Dai, Junqiang, Winham, Stacey J., Cunningham, Julie M., Natanzon, Yanina, Kalli, Kimberly R., Hou, Xiaonan, Weroha, S. John, Haluska, Paul, Lawrenson, Kate, Gayther, Simon A., Wang, Chen, Goode, Ellen L., Fridley, Brooke L.
Publicado 2017

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers

por Mehner, Christine, Oberg, Ann L., Kalli, Kimberly R., Nassar, Aziza, Hockla, Alexandra, Pendlebury, Devon, Cichon, Magdalena A., Goergen, Krista M., Maurer, Matthew J., Goode, Ellen L., Keeney, Gary L., Jatoi, Aminah, Sahin-Tóth, Miklós, Copland, John A., Radisky, Derek C., Radisky, Evette S.
Publicado 2015

CHFR and Paclitaxel Sensitivity of Ovarian Cancer

por Wahner Hendrickson, Andrea E., Visscher, Daniel W., Hou, Xiaonan, Goergen, Krista M., Atkinson, Hunter J., Beito, Thomas G., Negron, Vivian, Lingle, Wilma L., Bruzek, Amy K., Hurley, Rachel M., Wagner, Jill M., Flatten, Karen S., Peterson, Kevin L., Schneider, Paula A., Larson, Melissa C., Maurer, Matthew J., Kalli, Kimberly R., Oberg, Ann L., Weroha, S. John, Kaufmann, Scott H.
Publicado 2021

Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes

por Peedicayil, Abraham, Vierkant, Robert A., Hartmann, Lynn C., Fridley, Brooke L., Fredericksen, Zachary S., White, Kristin L., Elliott, Elaine A., Phelan, Catherine M., Tsai, Ya-Yu, Berchuck, Andrew, Iversen, Edwin S., Couch, Fergus J., Peethamabaran, Prema, Larson, Melissa C., Kalli, Kimberly R., Kosel, Matthew L., Shridhar, Vijayalakshmi, Rider, David N., Liebow, Mark, Cunningham, Julie M., Schildkraut, Joellen M., Sellers, Thomas A., Goode, Ellen L.
Publicado 2010

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

por Block, Matthew S., Dietz, Allan B., Gustafson, Michael P., Kalli, Kimberly R., Erskine, Courtney L., Youssef, Bahaaeldin, Vijay, Geraldine V., Allred, Jacob B., Pavelko, Kevin D., Strausbauch, Michael A., Lin, Yi, Grudem, Megan E., Jatoi, Aminah, Klampe, Carolyn M., Wahner-Hendrickson, Andrea E., Weroha, S. John, Glaser, Gretchen E., Kumar, Amanika, Langstraat, Carrie L., Solseth, Mary L., Deeds, Michael C., Knutson, Keith L., Cannon, Martin J.
Publicado 2020

TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer

por Chien, Jeremy, Sicotte, Hugues, Fan, Jian-Bing, Humphray, Sean, Cunningham, Julie M., Kalli, Kimberly R., Oberg, Ann L., Hart, Steven N., Li, Ying, Davila, Jaime I., Baheti, Saurabh, Wang, Chen, Dietmann, Sabine, Atkinson, Elizabeth J., Asmann, Yan W., Bell, Debra A., Ota, Takayo, Tarabishy, Yaman, Kuang, Rui, Bibikova, Marina, Cheetham, R. Keira, Grocock, Russell J., Swisher, Elizabeth M., Peden, John, Bentley, David, Kocher, Jean-Pierre A., Kaufmann, Scott H., Hartmann, Lynn C., Shridhar, Viji, Goode, Ellen L.
Publicado 2015